Showing results (191-200 of 317) with videos related to
Sort By:
Pageof 32
Molecular and Cellular Biology|September 1, 1996
HOXB7 constitutively activates basic fibroblast growth factor in melanomasA Caré, A Silvani, E Meccia, et al.International Journal of Cancer|March 15, 1982
Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c miceG Parmiani, M L Sensi, G Carbone, et al.International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.Tumori|December 31, 1987
A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effectsR Marolda, F Belli, A Prada, et al.Journal of Immunogenetics|October 1, 1983
Impaired H-2 expression in B16 melanoma variantsP Nanni, M P Colombo, C De Giovanni, et al.Cancer Research|February 1, 1996
Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cellsM Vagliani, M Rodolfo, F Cavallo, et al.Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion moleculesF Arienti, C Gambacorti-Passerini, L Borin, et al.Current Cancer Drug Targets|December 20, 2003
Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignanciesE Fonsatti, L Sigalotti, P Arslan, et al.Pageof 32